Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-04

FDA Approved: PRASUGREL — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

The FDA approved Amneal Pharmaceuticals LLC's supplemental application for prasugrel, granting approval of a generic prasugrel product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRASUGREL (prasugrel)

Snippet

SUPPL AP for PRASUGREL (PRASUGREL)